BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33279767)

  • 1. A comprehensive analytical process, from NPS threat identification to systematic screening: Method validation and one-year prevalence study.
    Garneau B; Desharnais B; Laquerre J; Côté C; Taillon MP; Martin PY; Daigneault G; Mireault P; Lajeunesse A
    Forensic Sci Int; 2021 Jan; 318():110595. PubMed ID: 33279767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a rapid LC-MS/MS method for the detection of 182 novel psychoactive substances in whole blood.
    Giorgetti A; Barone R; Pelletti G; Garagnani M; Pascali J; Haschimi B; Auwärter V
    Drug Test Anal; 2022 Feb; 14(2):202-223. PubMed ID: 34599648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel screening method for 64 new psychoactive substances and 5 amphetamines in blood by LC-MS/MS and application to real cases.
    Vaiano F; Busardò FP; Palumbo D; Kyriakou C; Fioravanti A; Catalani V; Mari F; Bertol E
    J Pharm Biomed Anal; 2016 Sep; 129():441-449. PubMed ID: 27490334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Forward-Thinking Approach to Addressing the New Synthetic Opioid 2-Benzylbenzimidazole Nitazene Analogs by Liquid Chromatography-Tandem Quadrupole Mass Spectrometry (LC-QQQ-MS).
    Walton SE; Krotulski AJ; Logan BK
    J Anal Toxicol; 2022 Mar; 46(3):221-231. PubMed ID: 34792157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatography-tandem mass spectrometry screening method using information-dependent acquisition of enhanced product ion mass spectra for synthetic cannabinoids including metabolites in urine.
    Staeheli SN; Veloso VP; Bovens M; Bissig C; Kraemer T; Poetzsch M
    Drug Test Anal; 2019 Sep; 11(9):1369-1376. PubMed ID: 31219237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and concentrations of new designer stimulants, synthetic opioids, benzodiazepines, and hallucinogens in postmortem hair samples: A 13-year retrospective study.
    Niebel A; Westendorf L; Krumbiegel F; Hartwig S; Parr MK; Tsokos M
    Drug Test Anal; 2022 Jan; 14(1):110-121. PubMed ID: 34435749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of Novel Psychoactive Substances in Postmortem Matrices by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS-MS).
    Fagiola M; Hahn T; Avella J
    J Anal Toxicol; 2018 Oct; 42(8):562-569. PubMed ID: 30371846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of a simultaneous screening method for the detection of new psychoactive substances in various matrix samples using liquid chromatography/electrospray ionization tandem mass spectrometry and liquid chromatography/quadrupole time-of-flight mass spectrometry.
    Kim NS; Lim NY; Choi HS; Lee JH; Kim H; Baek SY
    Rapid Commun Mass Spectrom; 2021 May; 35(10):e9067. PubMed ID: 33656207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a fast UPLC-MS/MS screening method for the detection of 68 psychoactive drugs and metabolites in whole blood and application to post-mortem cases.
    Barone R; Giorgetti A; Cardella R; Rossi F; Garagnani M; Pascali JP; Mohamed S; Fais P; Pelletti G
    J Pharm Biomed Anal; 2023 May; 228():115315. PubMed ID: 36889130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simple and rapid screening procedure for 143 new psychoactive substances by liquid chromatography-tandem mass spectrometry.
    Adamowicz P; Tokarczyk B
    Drug Test Anal; 2016 Jul; 8(7):652-67. PubMed ID: 25976069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of Traditional and Designer Benzodiazepines in Urine through LC-MS/MS.
    Rossi B; Freni F; Carelli C; Moretti M; Galatone D; Vignali C; Morini L
    Curr Pharm Des; 2022; 28(32):2622-2638. PubMed ID: 36045516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A data-independent acquisition workflow for qualitative screening of new psychoactive substances in biological samples.
    Kinyua J; Negreira N; Ibáñez M; Bijlsma L; Hernández F; Covaci A; van Nuijs AL
    Anal Bioanal Chem; 2015 Nov; 407(29):8773-85. PubMed ID: 26396082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case report: relevance of metabolite identification to detect new synthetic opioid intoxications illustrated by U-47700.
    Richeval C; Gaulier JM; Romeuf L; Allorge D; Gaillard Y
    Int J Legal Med; 2019 Jan; 133(1):133-142. PubMed ID: 30443678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analytical Strategies to Disclose Repeated Consumption of New Psychoactive Substances by Hair Analysis.
    Rotolo MC; Klein J; Pacifici R; Busardo FP; Pichini S; Marchei E
    Curr Pharm Biotechnol; 2017; 18(10):834-839. PubMed ID: 29173161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a sensitive untargeted liquid chromatography-high resolution mass spectrometry screening devoted to hair analysis through a shared MS2 spectra database: A step toward early detection of new psychoactive substances.
    Fabresse N; Larabi IA; Stratton T; Mistrik R; Pfau G; Lorin de la Grandmaison G; Etting I; Grassin Delyle S; Alvarez JC
    Drug Test Anal; 2019 May; 11(5):697-708. PubMed ID: 30394697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology - An update.
    Remane D; Wissenbach DK; Peters FT
    Clin Biochem; 2016 Sep; 49(13-14):1051-71. PubMed ID: 27452180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection and quantification of synthetic cathinones and selected piperazines in hair by LC-MS/MS.
    Niebel A; Krumbiegel F; Hartwig S; Parr MK; Tsokos M
    Forensic Sci Med Pathol; 2020 Mar; 16(1):32-42. PubMed ID: 31853826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput screening for new psychoactive substances (NPS) in whole blood by DLLME extraction and UHPLC-MS/MS analysis.
    Odoardi S; Fisichella M; Romolo FS; Strano-Rossi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Sep; 1000():57-68. PubMed ID: 26209771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of U-47700 and its metabolites in plasma by LC-MS/MS.
    Smith CR; Truver MT; Swortwood MJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():41-47. PubMed ID: 30849683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of 32 cathinone derivatives and other designer drugs in serum by comprehensive LC-QQQ-MS/MS analysis.
    Swortwood MJ; Boland DM; DeCaprio AP
    Anal Bioanal Chem; 2013 Feb; 405(4):1383-97. PubMed ID: 23180084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.